Viemed Healthcare, Inc.

DB:VIJ Stock Report

Market Cap: €232.2m

Viemed Healthcare (VIJ) Stock Overview

Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. More details

VIJ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 27.37% per year

Earnings grew by 19% over the past year

Risk Analysis

Volatile share price over the past 3 months compared to the German market


VIJ Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

INBS logo
Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
42.3% undervalued intrinsic discount
59.20%
Revenue growth p.a.
8users have liked this narrative
0users have commented on this narrative
39users have followed this narrative
25 days ago author updated this narrative

Viemed Healthcare, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Viemed Healthcare
Historical stock prices
Current Share PriceUS$5.60
52 Week HighUS$8.90
52 Week LowUS$5.30
Beta1.37
1 Month Change0%
3 Month Change-13.18%
1 Year Change-3.45%
3 Year Change9.80%
5 Year Change-34.12%
Change since IPO-9.87%

Recent News & Updates

Recent updates

Shareholder Returns

VIJDE HealthcareDE Market
7D2.8%2.2%2.6%
1Y-3.4%41.8%17.6%

Return vs Industry: VIJ underperformed the German Healthcare industry which returned 41.8% over the past year.

Return vs Market: VIJ underperformed the German Market which returned 17.6% over the past year.

Price Volatility

Is VIJ's price volatile compared to industry and market?
VIJ volatility
VIJ Average Weekly Movement10.5%
Healthcare Industry Average Movement5.3%
Market Average Movement5.7%
10% most volatile stocks in DE Market12.1%
10% least volatile stocks in DE Market3.0%

Stable Share Price: VIJ's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: VIJ's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20061,222Casey Hoytwww.viemed.com

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment.

Viemed Healthcare, Inc. Fundamentals Summary

How do Viemed Healthcare's earnings and revenue compare to its market cap?
VIJ fundamental statistics
Market cap€232.21m
Earnings (TTM)€10.43m
Revenue (TTM)€197.64m
22.2x
P/E Ratio
1.2x
P/S Ratio

Is VIJ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIJ income statement (TTM)
RevenueUS$232.79m
Cost of RevenueUS$96.11m
Gross ProfitUS$136.68m
Other ExpensesUS$124.39m
EarningsUS$12.29m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.31
Gross Margin58.71%
Net Profit Margin5.28%
Debt/Equity Ratio2.9%

How did VIJ perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/30 23:30
End of Day Share Price 2025/06/30 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Viemed Healthcare, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited
Vadim MerkulovFreedom Broker
Ilya ZubkovFreedom Broker